Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Cannabinoid Receptor I ELISA Kit (AC3949)
Cat.#: ASET-2538
Specifications
Description Human Cannabinoid Receptor I ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Cannabinoid Receptor I concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.14 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 3-48 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1294 Rat beta Arrestin 1 ELISA Kit (AC2705) Quantitative inquiry ASET-1075 Rat Slit3 ELISA Kit (AC2486) Quantitative inquiry ASET-1217 Mouse beta Catenin ELISA Kit (AC2628) Quantitative inquiry ASET-1218 Rat GAPDH ELISA Kit (AC2629) Quantitative inquiry ASET-2330 Human POMC ELISA Kit (AC3741) Quantitative inquiry ASET-2082 Human LAMB3 ELISA Kit (AC3493) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-1041 Mouse CORT ELISA Kit (AC2452) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1943 Mouse NK-2R ELISA Kit (AC3354) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket